Merza Z , Mah P , Blumsohn A , Meads D , Mckenna S , Wylie K , Eastell R , Ross R
ea0005p181 | Neuroendocrinology and Behaviour | BES2003
Mah P , Walters S , Newell-Price J , Webster J , Doane A , Ibbotson V , Hosker J , Jones T , Ho K , Eastell R , Ross R
ea0033s2.1 | Symposia 2 Recent advances in CAH management | BSPED2013
ea0029s57.2 | What's new in congenital adrenal hyperplasia (CAH)? | ICEECE2012
ea0024s17 | Symposium 1 – Transition and Therapeutics | BSPED2010
ea0006dp33 | Diabetes, metabolism and cardiovascular | SFE2003
ea0009p36 | Growth and development | BES2005
ea0006p48 | Growth and development | SFE2003
ea0002sp19 | <emphasis>Journal of Molecular Endocrinology</emphasis> Symposium: Receptor Antagonists | SFE2001
ea0049gp61 | Cardiovascular & Lipid Endocrinology | ECE2017
Sendur Suleyman Nahit , Wilkinson Ian R , Ross Richard J